Merck KGaA (OTCPK:MKGAF)
$ 150.5 1 (0.67%) Market Cap: 64.74 Bil Enterprise Value: 72.23 Bil PE Ratio: 22.23 PB Ratio: 2.18 GF Score: 92/100

Full Year 2021 Merck KGaA Earnings Call Transcript

Mar 03, 2022 / 01:00PM GMT
Release Date Price: $194.54 (-0.34%)
Operator

Dear ladies and gentlemen, welcome to the Merck Investor and Analyst Conference Call on Fourth Quarter 2021. (Operator Instructions)

May I now hand you over to Constantin Fest, Head of Investor Relations, who will lead you through this conference. Please go ahead, sir.

Constantin Fest
MERCK Kommanditgesellschaft auf Aktien - Head of IR

Thank you, John. Dear ladies and gentlemen, a very warm welcome from my side to this Q4 2021 earnings results call of Merck. My name is Constantin Fest, I'm Head of Investor Relations here at Merck. And I'm delighted to have here today with me Belen Garijo, CEO of the Merck Group; as well as Marcus Kuhnert, CFO of the Merck Group. For the Q&A, we will also be joined by Matthias Heinzel, CEO of Life Science; as well as Peter Guenter, CEO of Healthcare; and Kai Beckmann, CEO of Electronics.

We would like to first run you through the key slides of this presentation, and then we'll be happy to take all of your questions during the Q&A.

Having said this, I'd like to now hand over to Belen to kick

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot